Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention
References (3)
- et al.
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
Lancet
(2001)
There are more references available in the full text version of this article.
Cited by (33)
Meta-Analysis of Aspirin Versus Dual Antiplatelet Therapy Following Coronary Artery Bypass Grafting
2018, American Journal of CardiologyDual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights
2017, Journal of the American College of CardiologyDual antiplatelet therapy use by Canadian cardiac surgeons
2015, Journal of Thoracic and Cardiovascular SurgeryDual antiplatelet therapy after coronary artery bypass grafting in the setting of acute coronary syndrome
2015, American Journal of CardiologyCitation Excerpt :Additional studies were discovered during bibliographic reviews. A total of 12 studies including efficacy end points were identified on this subject with varying results.11–22 In general, the studies conducted to date include small patient populations with surrogate end points.
Effect of clopidogrel use post coronary artery bypass surgery on graft patency
2014, Annals of Thoracic Surgery
The CREDO trial was supported by Sanofi-Synthelabo, Inc./Bristol Myers Squibb Partnership, New York, New York.
- *
A list of the investigators appears in JAMA 2002;288:2411–2420.
Copyright © 2004 Excerpta Medica Inc. All rights reserved.